| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8240239 | International Journal of Radiation Oncology*Biology*Physics | 2007 | 8 Pages |
Abstract
Cevimeline 45 mg t.i.d. was generally well tolerated over a period of 52 weeks in subjects with xerostomia secondary to radiotherapy for cancer in the head-and-neck region.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Mark S. D.M.D., M.S., Christopher Uwe M.D., Merrill A. M.D., Ph.D., Randal S. M.D., Kenneth M. M.D., Y. M.D. Ph.D., John M. M.D., Jonathan A. D.M.D., Robert M.D., M.B.A., Ingrid M.S., Adam S. M.D., Robert M.D.,